Drugmaker Pfizer starts low with 2023 earnings forecast
Pfizer surprised Wall Street by predicting a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment. |!| Oklahoma City
More from Frontier Country
The Oklahoma Daily | Oklahoma
OU football head coach contract details: What is Brent Venables' buyout?
Frontier Country
•
4h ago
The Oklahoma Daily | Oklahoma
Sooners look to take next step in 2026-27: OU women's basketball media day
Frontier Country
•
4h ago
The Oklahoma Daily | Oklahoma
Why Lloyd Avant's OU success comes as 'no surprise'
Frontier Country
•
4h ago
KTUL 8 Tulsa
Bette Midler accepts 2026 Woody Guthrie Prize, joined by Bryan Andrews in Tulsa
Frontier Country
•
6h ago
